ICNP
iCoreConnect Inc. develops and markets health insurance portability and accountability act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company offers iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, an add-on for iCoreRx that integrates with state databases to automate prescription drug monitoring; iCoreVerify and iCoreVerify+, a HIP… Read more
ICNP (ICNP) - Net Assets
Latest net assets as of December 2024: $-9.79 Million USD
Based on the latest financial reports, ICNP (ICNP) has net assets worth $-9.79 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.69 Million) and total liabilities ($15.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-9.79 Million |
| % of Total Assets | -172.11% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 48.26 |
ICNP - Net Assets Trend (2019–2024)
This chart illustrates how ICNP's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ICNP (2019–2024)
The table below shows the annual net assets of ICNP from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-9.79 Million | -320.40% |
| 2023-12-31 | $4.44 Million | +277.66% |
| 2022-12-31 | $-2.50 Million | -348.83% |
| 2021-12-31 | $1.01 Million | +259.84% |
| 2020-12-31 | $-628.94K | -235.26% |
| 2019-12-31 | $465.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to ICNP's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7390044100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $138.45 Million | % |
| Total Equity | $-9.79 Million | 100.00% |
ICNP Competitors by Market Cap
The table below lists competitors of ICNP ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
STEEL DYNAMICS - Dusseldorf Stock Exchang
DU:SD5
|
$1.51 Million |
|
PT BK PANIN DU. SY. RP100
F:2PS
|
$1.51 Million |
|
Pure Foods Tasmania Ltd
AU:PFT
|
$1.52 Million |
|
JAZZ PHARMACEUTICAL (J7Z.SG)
STU:J7Z
|
$1.52 Million |
|
BioRestorative Therapies Inc
NASDAQ:BRTX
|
$1.51 Million |
|
BSF Enterprise Plc
PINK:BSFAF
|
$1.51 Million |
|
Mystic Holdings Inc.
OTCQB:MSTH
|
$1.51 Million |
|
C.H.ROBINSON WLDWDE - Dusseldorf Stock Exchang
DU:CH1A
|
$1.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ICNP's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,444,168 to -9,794,974, a change of -14,239,142 (-320.4%).
- Net loss of 31,156,817 reduced equity.
- New share issuances of 412,564 increased equity.
- Other factors increased equity by 16,505,111.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-31.16 Million | -318.09% |
| Share Issuances | $412.56K | +4.21% |
| Other Changes | $16.51 Million | +168.51% |
| Total Change | $- | -320.40% |
Book Value vs Market Value Analysis
This analysis compares ICNP's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.01 | $0.34 | x |
| 2020-12-31 | $-0.01 | $0.34 | x |
| 2021-12-31 | $0.01 | $0.34 | x |
| 2022-12-31 | $-8.23 | $0.34 | x |
| 2023-12-31 | $8.83 | $0.34 | x |
| 2024-12-31 | $-4.74 | $0.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ICNP utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -289.93%
- • Asset Turnover: 1.89x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-247.54%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -641.51% | -294.18% | 0.40x | 5.42x | $-3.03 Million |
| 2020 | 0.00% | -164.40% | 0.79x | 0.00x | $-3.43 Million |
| 2021 | -493.81% | -100.15% | 0.75x | 6.60x | $-5.06 Million |
| 2022 | 0.00% | -76.11% | 1.22x | 0.00x | $-5.83 Million |
| 2023 | -349.93% | -190.78% | 0.52x | 3.53x | $-16.00 Million |
| 2024 | 0.00% | -289.93% | 1.89x | 0.00x | $-30.18 Million |
Industry Comparison
This section compares ICNP's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ICNP (ICNP) | $-9.79 Million | -641.51% | N/A | $1.51 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |